Search Results - "Danner, S. A."

Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4$^+$ T Cells by Z.-Q. Zhang, Schuler, T., Zupancic, M., Wietgrefe, S., Staskus, K. A., Reimann, K. A., Reinhart, T. A., Rogan, M., Cavert, W., Miller, C. J., Veazey, R. S., Notermans, D., Little, S., Danner, S. A., Richman, D. D., Havlir, D., Wong, J., Jordan, H. L., Schacker, T. W., Racz, P., Tenner-Racz, K., Letvin, N. L., Wolinsky, S., Haase, A. T.

“…In sexual transmission of simian immunodeficiency virus, and early and later stages of human immunodeficiency virus-type 1 (HIV-1) infection, both viruses were…”
Get full text

Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection by VAN DER VALK, M, GISOLF, E. H, REISS, P, WIT, F. W. N. M, JAPOUR, A, WEVERLING, G. J, DANNER, S. A

“…Changes in body fat distribution are an adverse effect of therapy with HIV protease inhibitors (PI). It has been suggested that nucleoside analogue reverse…”
Get full text

A Context-Learning Pharmacotherapy Program for Preclinical Medical Students Leads to More Rational Drug Prescribing During Their Clinical Clerkship in Internal Medicine by Richir, MC, Tichelaar, J, Stam, F, Thijs, A, Danner, SA, Schneider, AJ, Vries, ThPGM

“…The irrational prescribing of drugs seems to be a general problem in medical practice, occasionally leading to serious consequences. In order to improve the…”
Get full text

Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC) by Schuurman, Rob, Nijhuis, Monique, van Leeuwen, Remko, Schipper, Pauline, de Jong, Dorien, Collis, Phil, Danner, Sven A., Mulder, John, Loveday, Clive, Christopherson, Cindy, Kwok, Shirley, Sninsky, John, Boucher, Charles A. B.

“…The effect of the appearance of drug-resistant human immunodeficiency virus type 1 (HIV-1) on viral RNA load was studied in patients treated with the reverse…”
Get full text

Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 Infection by Cavert, Winston, Notermans, Daan W., Staskus, Katherine, Wietgrefe, Stephen W., Zupancic, Mary, Gebhard, Kristin, Henry, Keith, Zhang, Zhi-Qiang, Mills, Roger, McDade, Hugh, Goudsmit, Jaap, Danner, Sven A., Haase, Ashley T.

“…In lymphoid tissue, where human immunodeficiency virus-type 1 (HIV-1) is produced and stored, three-drug treatment with viral protease and reverse…”
Get full text

Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases by ter Hofstede, H J, de Marie, S, Foudraine, N A, Danner, S A, Brinkman, K

“…Our objective was to describe clinical features and predisposing factors attributed to lactic acidosis in 4 HIV-infected patients on long-term nucleoside…”
Get more information

Outcome and Predictors of Failure of Highly Active Antiretroviral Therapy: One-Year Follow-Up of a Cohort of Human Immunodeficiency Virus Type 1-Infected Persons by Wit, Ferdinand W. N. M., van Leeuwen, Remko, Weverling, Gerrit Jan, Jurriaans, Suzanne, Nauta, Klaas, Steingrover, Radjin, Schuijtemaker, Johan, Eyssen, Xander, Fortuin, David, Weeda, Marjan, de Wolf, Frank, Reiss, Peter, Danner, Sven A., Lange, Joep M. A.

“…The outcome and predictors of virologic treatment failure of highly active antiretroviral therapy (HAART) were determined for 271 human immunodeficiency virus…”
Get full text

Functional T Cell Reconstitution and Human Immunodeficiency Virus—1—Specific Cell-Mediated Immunity during Highly Active Antiretroviral Therapy by Pontesilli, Oscar, Kerkhof-Garde, Susana, Notermans, Daan W., Foudraine, Norbert A., Roos, Marijke T. L., Klein, Michèl R., Danner, Sven A., Lange, Joep M. A., Miedema, Frank

“…Lymphoproliferative responses (LPRs) to recall antigens (Ags) and human immunodeficiency virus type 1 (HIV-1) Gag and frequencies of circulating HIV-1—specific…”
Get full text

Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men: HIV affects the immune system before CD4+ T helper cell depletion occurs by MIEDEMA, F, PETIT, A. J. C, SCHELLEKENS, P. T. A, TERPSTRA, F. G, SHCATTENKERK, J. K. M. E, DE WOLF, F, AL, B. J. M, ROOS, M, LANGE, J. M A, DANNER, S. A, GOUDSMIT, J

“…To investigate the effect of persistent HIV infection on the immune system, we studied leukocyte functions in 14 asymptomatic homosexual men (CDC group II/III)…”
Get full text

Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs by DE JONG, J. J, GOUDSMIT, J, LUKASHOV, V. V, HILLEBRAND, M. E, BAAN, E, HUISMANS, R, DANNER, S. A, TEN VEEN, J. H, DE WOLF, F, JURRIAANS, S

“…To identify genotypic drug resistance patterns of HIV-1 in patients who were extensively pretreated with anti-HIV drugs and not responding to their current…”
Get full text

Immune Reconstitution after 2 Years of Successful Potent Antiretroviral Therapy in Previously Untreated Human Immunodeficiency Virus Type 1-Infected Adults by Notermans, Daan W., Pakker, Nadine G., Hamann, Dörte, Foudraine, Norbert A., Kauffmann, Robert H., Meenhorst, Pieter L., Goudsmit, Jaap, Roos, Marijke T. L., Schellekens, Peter T. A., Miedema, Frank, Danner, Sven A.

“…Today's antiretroviral combination regimens can induce significant and sustained decreases in human immunodeficiency virus (HIV)-RNA levels, allowing the…”
Get full text

Effects of nandrolone decanoate compared with placebo or testosterone on HIV‐associated wasting by Gold, J, Batterham, MJ, Rekers, H, Harms, MK, Geurts, TBP, Helmyr, PME, Silva de Mendonça, J, Falleiros Carvalho, LH, Panos, G, Pinchera, A, Aiuti, F, Lee, C, Horban, A, Gatell, J, Phanuphak, P, Prasithsirikul, W, Gazzard, B, Bloch, M, Danner, SA

“…Objectives Current research is unclear about the most effective pharmacological agents for managing the loss of weight and fat‐free mass common in HIV/AIDS…”
Get full text

Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell lines by Bierman, Wouter F. W., Scheffer, George L., Schoonderwoerd, Antoinet, Jansen, Gerrit, van Agtmael, Michiel A., Danner, Sven A., Scheper, Rik J.

“…Objectives A possible mechanism for HIV therapy failure is the efflux of HIV drugs from viral target cells or certain body compartments by ATP-binding cassette…”
Get full text

Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine by GISOLF, E. H, ENTING, R. H, JURRIAANS, S, DE WOLF, F, VAN DER ENDE, M. E, HOETELMANS, R. M. W, PORTEGIES, P, DANNER, S. A

“…To assess the HIV-1-RNA response and drug concentrations in cerebrospinal fluid (CSF) and serum during treatment with saquinavir (SQV)/ritonavir (RTV) or…”
Get full text

Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy by WEVERLING, G. J, LANGE, J. M. A, GOUDSMIT, J, DE WOLF, F, JURRIAANS, S, PRINS, J. M, LUKASHOV, V. V, NOTERMANS, D. W, ROOS, M, SCHUITEMAKER, H, HOETELMANS, R. M. W, DANNER, S. A

“…To compare the viral suppression of two antiretroviral regimens using three drugs or five drugs. Two open-label studies using a three-drug (zidovudine,…”
Get full text

Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen by NOTERMANS, D. W, GOUDSMIT, J, DANNER, S. A, DE WOLF, F, PERELSON, A. S, MITTLER, J

“…The dynamics uf viral decline following the initiation of antiretroviral treatment were studied in 29 HIV-1-infected patients participating in a two-arm trial…”
Get full text

Macronodular adrenocortical hyperplasia in a postmenopausal woman by MIJNHOUT, G. S, DANNER, S. A, VAN DE GOOT, F. R. W, VAN DAM, E. W. C. M

“…This case report describes the diagnosis of Cushing's syndrome due to macronodular adrenal hyperplasia in an elderly woman who presented with fatigue, muscle…”
Get full text

Evaluation of Safety and Efficacy of 3TC (Lamivudine) in Patients with Asymptomatic or Mildly Symptomatic Human Immunodeficiency Virus Infection: A Phase I/II Study by van Leeuwen, Remko, Katlama, Christine, Kitchen, Valerie, Boucher, Charles A. B., Tubiana, Roland, McBride, Michael, Ingrand, Didier, Weber, Jonathan, Hill, Andrew, McDade, Hugh, Danner, Sven A.

“…In a phase 1/11 study, 7 levelsof3TC therapy (from 0.5 to 20.0 mg/kg/day) were studied in 104 asymptomatic and mildly symptomatic human immunodeficiency…”
Get full text

Prevalence of Campylobacter-Associated Diarrhea Among Patients Infected with Human Immunodeficiency Virus by Snijders, Fransje, Kuijper, E. J., de Wever, B., van der Hoek, L., Danner, S. A., Dankert, J.

“…We performed a cross-sectional study at an outpatient AIDS clinic to assess the prevalence of Campylobacter species in stool specimens from 201 consecutive…”
Get full text

Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapy by KOSTENSE, S, RAAPHORST, F. M, NOTERMANS, D. W, JOLING, J, HOOIBRINK, B, PAKKER, N. G, DANNER, S. A, TEALE, J. M, MIEDEMA, F

“…Highly active antiretroviral therapy (HAART) induces a decline in viral load and a biphasic increase in peripheral blood CD4+ T-cell counts in HIV-infected…”
Get full text